![Alfred E. Slanetz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alfred E. Slanetz
Fondateur chez Geneius Biotechnology, Inc.
Postes actifs de Alfred E. Slanetz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Geneius Biotechnology, Inc.
![]() Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Directeur/Membre du Conseil | 01/01/2015 | - |
Directeur Général | 01/01/2015 | - | |
Fondateur | 01/01/2015 | - | |
President | 01/01/2015 | - | |
Aim-Hi Accelerator Fund, Inc.
![]() Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Alfred E. Slanetz
Anciens postes connus de Alfred E. Slanetz
Sociétés | Poste | Début | Fin |
---|---|---|---|
TRANSGENE | Corporate Officer/Principal | - | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
BLUEBIRD BIO, INC. | President | 01/01/2007 | - |
Formation de Alfred E. Slanetz
Yale University | Doctorate Degree |
Brown University | Graduate Degree |
Hamilton College (New York) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
France | 2 |
Opérationnelle
President | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
TRANSGENE | Health Technology |
Entreprise privées | 3 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Geneius Biotechnology, Inc.
![]() Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Commercial Services |
Aim-Hi Accelerator Fund, Inc.
![]() Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Alfred E. Slanetz
- Expérience